Can contrast-enhanced MR imaging predict survival in breast cancer?

Acta Radiologica

Volumn 44, Issue 4, 2003, Pages 373-378

  Bone, B ^a   Szabó, Botond K ^a   Perbeck, L G ^a   Veress, B ^b   Aspelin, P ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Breast cancer; MR; Prognostic markers, survival analysis

Indexed keywords

BREAST CANCER;

DISEASES; HISTOLOGY; MAGNETIC RESONANCE IMAGING; PATHOLOGY; STATISTICAL METHODS; TUMORS;

DIAGNOSTIC RADIOGRAPHY;

CONTRAST MEDIUM;

ARTICLE; BREAST TUMOR; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; METHODOLOGY; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PREDICTION AND FORECASTING; PROGNOSIS; SURVIVAL; TIME;

BREAST NEOPLASMS; CONTRAST MEDIA; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 0041976996     PISSN: 02841851     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0455.2003.00080.x     Document Type: Article

References (17)

1. American Joint Committee on Cancer, American Cancer Society, American College of Surgeons: AJCC cancer staging manual, 5th edn. Lippincott-Raven 1997.
2. Boetes C, Mus RD, Holland R et al. Breast tumors: comparative accuracy of MR imaging relative to mammography and US for demonstrating extent. Radiology 1995; 197: 743-47.
3. Boné B, Aspelin P, Bronge L, Veress B. Contrast-enhanced MR imaging as a prognostic indicator of breast cancer. Acta Radiol. 1998; 39: 279-84.
4. Carter CL, Allen C, Henson DE. Relation of tumor size, lymph node status, and survival in 24, 740 breast cancer cases. Cancer 1989; 63: 181-87.
5. Elston CW, Ellis IO, Pinder SE. Review article. Pathological prognostic factors in breast cancer. Crit. Rev. Oncol. Hematol. 1999; 31: 209-23.
6. Esserman L, Hylton N, George T, Weidner N. Contrast-enhanced magnetic resonance imaging to assess tumor histopathology and angiogenesis in breast carcinoma. Breast J. 1999; 5: 13-21.
7. Fridman V, Humblet C, Bonjean K, Boniver J. Assessment of tumor angiogenesis in invasive breast carcinomas: absence of correlation with prognosis and pathological factors. Virchows Arch. 2000; 437: 611-17.
8. Gilles R, Guinebretiere JM, Toussaint C et al. Locally advanced breast cancer: contrast-enhanced subtraction MR imaging of response to preoperative chemotherapy. Radiology 1994; 191: 633-38.
9. Hawighorst H, Weikel W, Knapstein PG et al. Angiogenic activity of cervical carcinoma: assessment by functional magnetic resonance imaging-based parameters and a histomorphological approach in correlation with disease outcome. Clin. Cancer Res. 1998; 4: 2305-312.
10. Hothorn T, Lausen B. On the exact distribution of maximally selected rank statistics. Comp. Stat. Data Anal. xx 2003; xxx: (in press). Preprint available from: URL: http://www. mathpreprints.com/math/Preprint/hothorn/20020227/2.
11. Ihaka R, Gentleman R.R: A language for data analysis and graphics. J. Comp. Graph. Stat.1996; 5: 299-314.
12. Mayr NA, Yuh WT, Magnotta VA et al. Tumor perfusion studies using fast magnetic resonance imaging technique in advanced cervical cancer: a new noninvasive predictive assay. Int. J. Radiat. Oncol. Biol. Phys. 1996; 36: 623-33.
13. Mussurakis S, Buckley DL, Horsman A. Dynamic MR imaging of invasive breast cancer: correlation with tumour grade and other histological factors. Br. J. Radiol. 1997; 70: 446-51.
14. Orel SG, Schnall MD. MR imaging of the breast for the detection, diagnosis, and staging of breast cancer. Radiology 2001; 220: 13-30.
15. Reddick WE, Wang S, Xiong X et al. Dynamic magnetic resonance imaging of regional contrast access as an additional prognostic factor in pediatric osteosarcoma. Cancer 2001; 91: 2230-37.
16. Stomper PC, Herman S, Klippenstein DL, Winston JS, Budnick RM, Stewart CC. Invasive breast carcinoma: analysis of dynamic magnetic resonance imaging enhancement features and cell proliferative activity determined by DNA S-phase percentage. Cancer 1996; 77: 1844-49.
17. Tahan SR, Neuberg DS, Dieffenbach A, Yacoub L. Prediction of early relapse and shortened survival in patients with breast cancer by proliferating cell nuclear antigen score. Cancer 1993; 71: 3552-59.